| Patient | Bob Marley |
|---|---|
| Date of birth | 1994-02-06 |
| Identifiers | MRN HR-ML027-SYN; SSN (made up) 000-27-4065 |
| Document date | 2026-10-19 |
| Author | Desmond Clarke, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Melanoma review about three and a half months after surgery. [S]
Mr. Marley returns for his first melanoma surveillance visit, about three and a half months after digit-sparing excision of a stage IA acral melanoma of the right great toe. The graft is fully healed, and he runs and plays football without pain; he still wears the ankle support for football since the sprain eight weeks ago, which has healed. He has examined his skin and nails each month with a mirror and photographed the graft; he has seen no change. His HIV, hepatitis B, and hepatitis C tests from the preventive visit were negative, with no immunity to hepatitis B, and he is due the second hepatitis B vaccine. He leaves on tour next week. He has had no thoughts of self-harm. [S]
| Element | Detail |
|---|---|
| Graft | Healed; no change on his monthly photographs |
| Activity | Running and football without pain |
| Self-examination | Monthly, including the soles and nails |
| Results | HIV, hepatitis B surface antigen, and hepatitis C antibody negative; not immune to hepatitis B |
| Plans | Touring from next week |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight loss, fever, or night sweats |
| Respiratory | Negative | No cough |
| Neurological | Negative | No headache |
| Integumentary | Negative | No new bands, spots, or sores |
| Hematologic and lymphatic | Negative | No lumps in the groin or behind the knee |
| Musculoskeletal | Negative | Ankle and toe pain-free |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day | Two tablets every 6 hours as needed | Oral route | 2026-07-01 to 2026-07-10 | completed | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth three times daily with food for up to 5 days | One tablet three times daily with food for up to 5 days | Oral route | 2026-08-24 to 2026-08-28 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-19 | Body height | 170 | cm | S |
| 2026-10-19 | Body weight | 66.4 | kg | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 2026-10-19 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-10-19 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-19 | Heart rate | 60 | /min | S |
| 2026-10-19 | Respiratory rate | 14 | /min | S |
| 2026-10-19 | Body temperature | 36.6 | Cel | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-19 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 0 | {score} | S | ||
| 2026-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 118/74, pulse 60; weight 66.4 kg |
| Right great toe | Graft fully healed, smooth and adherent, with no pigment, nodule, or ulcer at the graft or its edges |
| Lymph nodes | No popliteal or inguinal nodes on either side; no axillary or cervical nodes |
| Skin and nails | Full skin examination including the scalp, palms, soles, between the toes, and all nails: no suspicious lesion |
| Right ankle | No swelling; stable; full range |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| A brown-black band in the right great toenail, about 5 mm wide (about a third of the nail), with irregular dark lines, first noticed about two months ago after a knock at football and not growing out with the nail; the pigment extends onto the skin of the proximal nail fold (Hutchinson sign). Suspected subungual melanoma; dermoscopy and a full-thickness nail matrix biopsy booked this week | resolved | confirmed | L60.8 | S — Synthetic presenting problem linked to his documented toe lesion; superseded by the diagnosis at the surgical oncology consultation. |
| Acral lentiginous melanoma of the nail unit (subungual) of the right great toe, on full-thickness nail matrix biopsy: Breslow thickness 0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion; clinical stage IB (cT1b N0 M0); synthetic modern detail linked to his documented acral lentiginous melanoma | active | confirmed | C43.71 | S — Synthetic thickness and stage; the site, the subtype, and the year are documented (D). |
| Lateral sprain of the right ankle (anterior talofibular ligament) from an inversion injury at football; Ottawa ankle rules negative, so no X-ray; resolved | resolved | confirmed | S93.401A | S — Synthetic acute injury; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Full skin and nail examination, including the scalp, palms, soles, between the toes, and all nails | At diagnosis, then at each surveillance visit | Completed today | No suspicious lesion |
| Examination | Graft and scar | Each surveillance visit | Completed today | Healed; no pigment or nodule |
| Examination | Examination of the lymph node basins (right popliteal and inguinal) and the scar | At diagnosis, then at each surveillance visit | Completed today | No nodes |
| Imaging | Imaging (CT, PET, or ultrasound) and LDH | Not routine for stage I to II without symptoms | Not indicated | Stage IA without symptoms |
| Self-management | Skin self-examination | Monthly, taught after diagnosis and reviewed each visit | Completed today | Done monthly with graft photographs; technique reviewed |
| Referral | Dermatology full skin examination | Yearly | Due | Booked for the spring |
| Survey | Pain score | Each visit after surgery | Completed today | No pain |
| Survey | Depression screen (PHQ-2) | At each phase of care | Completed today | PHQ-2 score 0 |
Goal progress:
Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2 [S]
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous, Version 3.2026 (2026); Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80(1):208-250 (2019); Chouquet L, et al. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J Clin Med 2025;14(17):5932 (2025); Depression and Suicide Risk in Adults: Screening (2023); Adult Immunization Schedule by Age (2026)
Follow-up: Second hepatitis B vaccine dose given today, completing the series. Melanoma review in six months, or sooner for any new change. Dermatology in the spring. [S]